Cannabis Use Patterns Among Cancer Patients

NCT05132842 | Completed

• 3 other identifiers: 21F.175P30CA056036-21S3JT 16464
• Study Type: observational
• Target: 1,568
• Locations: 1 country
• Sites: 1

Brief Summary

This study determines patterns of cannabis use among cancer patients. Information collected in this study may help doctors to understand patient use of cannabis therapy, their knowledge and experiences with this therapy, benefits and risks associated with its use, and whether or to what extent they are discussing it with their health care providers.

Conditions

Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm

Outcome Measures

Primary Outcomes (1)

• Survey data analysis

  Respondent demographics and clinical characteristics and survey responses

  Up to 12 months

Study Arms (1)

Observational (survey)

Patients complete a survey about knowledge and awareness of medical cannabis, perceived risks and benefits of cannabis, mode and frequency of use (if applicable), impact on cancer-related symptoms, patient provider discussions about cannabis, and demographic characteristics including health and digital literacy.

Other: Survey Administration

Interventions

Survey Administration OTHER

Complete a Survey

Observational (survey)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients who had at least one medical or radiation oncology appointment within last 3 years at Sidney Kimmel Cancer Center (SKCC) cancer centers

You may qualify if:

• Provide signed and dated informed consent form
• English speaking
• Willing to comply with all study procedures and be available for the duration of the study
• Any individual \>= 18 years old
• At least one medical or radiation oncology appoint within the last 3 years at one of the SKCC cancer center campuses

You may not qualify if:

• Non-English speaking
• Not a cancer patient at one of the SKCC campuses
• Deceased

Sponsors & Collaborators

• Thomas Jefferson University: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, 19107, United States

Location

MeSH Terms

Conditions

Hematologic Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 2, 2021
• First Posted: November 24, 2021
• Study Start: February 25, 2021
• Primary Completion: October 29, 2022
• Study Completion: October 29, 2022
• Last Updated: May 15, 2025

Record last verified: 2025-05

Locations

US (1)